Search Results - "Balmuri, Shravya"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Complete Remission of Advanced Hepatocellular Carcinoma in a Patient With Ulcerative Colitis Treated With Atezolizumab and Bevacizumab: A Case Report by Pentapati, Swetha, Caucci, Stephen, Balmuri, Shravya, Devarkonda, Vishal

    Published in Curēus (Palo Alto, CA) (26-05-2023)
    “…In this case study, a 73-year-old man who had previously undergone colectomy had a history of ulcerative colitis and alcohol abuse and presented with fatigue,…”
    Get full text
    Journal Article
  2. 2

    A Rare Case of Hashimoto’s Encephalopathy With Mosaic Turner Syndrome by Chelikani, Vijaya, Rao, Deepti N, Balmuri, Shravya, Arida, Abdul K

    Published in Curēus (Palo Alto, CA) (20-08-2022)
    “…Mosaicism in Turner syndrome (TS) is a 20%-30% occurrence, with 45, X plus at least another cell line. The haploinsufficiency of the X chromosome is usually…”
    Get full text
    Journal Article
  3. 3

    Novel Approach in Cardiac Sarcoidosis: A Case Report Highlighting Abatacept as a Promising Treatment Option by Venkataraj, Maamannan, Pierotti, Tyler, Sondhi, Manush, Balmuri, Shravya, Hayat, Samina

    Published in Curēus (Palo Alto, CA) (23-09-2023)
    “…Cardiac sarcoidosis (CS) is a rare auto-immune disorder where immune cells form granulomas in the heart that may lead to potential arrhythmias and heart…”
    Get full text
    Journal Article
  4. 4

    Osteitis Condensans Illi – An overlooked cause of low back pain mimicking sacroiliitis by Bashyal, Krishna, Dhungana, Kamal, Yadav, Deepesh, Poudel, Dilli Ram, Ghimire, Calvin, Balmuri, Shravya

    Published in Clinical case reports (01-06-2023)
    “…Osteitis Condensans Illi (OCI) is an underrecognized cause of low back pain involving iliac bones with relative sparing of sacroiliac joint. We present a case…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Tisagenlecleucel in the treatment of aggressive large B-cell lymphoma: A review of literature by Devarkonda, Vishal, Balmuri, Shravya, Ponna, Pramod Kumar, Devarashetty, Sindhu Priya

    Published in Journal of clinical oncology (01-06-2022)
    “…e19563 Background: Tisagenlecleucel is an anti-CD19 chimeric antigen receptor T-cell therapy approved for refractory diffuse large B-cell lymphoma(DLBCL) in…”
    Get full text
    Journal Article
  7. 7

    Real-world experience with atezolizumab plus bevacizumab in the management of non-resectable hepatocellular carcinoma refractory to first-line systemic therapy: Review of literature by Devarkonda, Vishal, Byreddi, Laxman Yashwant, Balmuri, Shravya, Gudi, Thulasi, Gaddam, Shiva Jashwanth, Keerty, Dinesh

    Published in Journal of clinical oncology (01-06-2023)
    “…e16189 Background: Hepatocellular carcinoma is the fifth most common cancer worldwide and the third leading cause of cancer-associated deaths. In 2020, the…”
    Get full text
    Journal Article
  8. 8

    Comparison of time of onset of leukemia with patients receiving adalimumab vs other TNF α inhibitors by Devarkonda, Vishal, Balmuri, Shravya, Gaddam, Shiva Jashwanth, Keerty, Dinesh, Akabane, Hugo

    Published in Journal of clinical oncology (01-06-2023)
    “…e19034 Background: TNF α (Tumor necrosis factor alpha) inhibitors were first approved by US FDA (Food and drug administration) in the late 1990s to manage…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Adalimumab-associated Philadelphia chromosome positive acute lymphoblastic leukaemia in a patient with Crohn's disease by Devarkonda, Vishal, Balmuri, Shravya, Akabane, Maria Antonia Costa Cruz, Akabane, Hugo

    Published in BMJ case reports (24-10-2023)
    “…The US Food and Drug Administration has approved TNF(Tumor necrosis factor) alpha inhibitors to manage a range of inflammatory conditions, including Crohn's…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15